Literature DB >> 10483500

[Sensitivity of Corynebacterium diphtheriae isolated in Saint-Petersburg to antibacterial drugs].

D P Gladin1, N S Kozlova, T K Zaĭtseva, A S Cherednichenko, S A Khval'.   

Abstract

One hundred and thirty strains of Corynebacterium diphtheriae isolated in St. Petersburg (42 toxigenic and 88 nontoxigenic) were tested with the method of serial dilutions in solid media for their susceptibility to 20 antibacterial drugs. The MICs of the drugs for the isolates ranged from < or = 0.015 to > or = 32.0 micrograms/ml. 13 per cent of the isolates was resistant at least to one antibacterial drug. The isolates resistant to erythromycin (11.5 per cent), lincomycin (11.5 per cent) and trimethoprim (8.5 per cent) were most frequent. 3 isolates (2.3 per cent) had multiple resistance to 8 drugs: benzylpenicillin, ampicillin, oxacillin, chloramphenicol, erythromycin, lincomycin, trimethoprim, and nitroxolin. No significant differences in the susceptibility of the toxigenic and nontoxigenic strains of C. diphtheriae were detected. Gentamicin, rifampicin, tetracycline, doxycycline and pefloxacin were the most active antibiotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483500

Source DB:  PubMed          Journal:  Antibiot Khimioter        ISSN: 0235-2990


  2 in total

1.  Diphtheria outbreak in Maranhão, Brazil: microbiological, clinical and epidemiological aspects.

Authors:  L S Santos; L O Sant'anna; J N Ramos; E M Ladeira; R Stavracakis-Peixoto; L L G Borges; C S Santos; F Napoleão; T C F Camello; G A Pereira; R Hirata; V V Vieira; L M S S Cosme; P S Sabbadini; A L Mattos-Guaraldi
Journal:  Epidemiol Infect       Date:  2015-03       Impact factor: 4.434

2.  First-line antibiotic susceptibility pattern of toxigenic Corynebacterium diphtheriae in Indonesia.

Authors:  Dominicus Husada; Sugi Deny Pranoto Soegianto; Indra Suwarin Kurniawati; Adi Pramono Hendrata; Eveline Irawan; Leny Kartina; Dwiyanti Puspitasari; Parwati Setiono Basuki
Journal:  BMC Infect Dis       Date:  2019-12-11       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.